Home \ Expert Opinion \ Comorbid Patient

Comorbid patient

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:45
Recommendations of komorbid pathology
01:21
The difference between polymorbid and comorbid pathology
03:00
Charleson Comorbus Evaluation
04:30
Comorbidity phenotypes in age -related patients
05:09
Arterial hypertension and chronic brain ischemia
05:52
Polypragmasis, risks and ways to avoid
14:49
Evidence of neurocytoprotectors medicine
16:02
Mexidol® - Studies of efficiency and safety
16:41
Mexidol® - efficiency and subanalism by age groups

Ostroumova Olga Dmitrievna - MD, professor, head. Department of Therapy and Polymorbid Pathology. Academician M.S. VLUSSi FSBEI DPO RMANPO of the Ministry of Health of Russia

Pereverzev Anton Pavlovich - Ph.D., Associate Professor of the Department of Therapy and Polymorbid Pathology of the Federal State Budgetary Institution of the DPO RMANPO of the Ministry of Health of Russia

Announcement:

There are many terms in the literature to describe a combined pathology. However, the key difference is the presence of a pathogenetic connection between diseases. If several diseases are pathogenetically interconnected, then this is comorbidity. With polymorbidity, the disease can be both pathogenetically or not related - this is a broader concept. It is very important to avoid polypragmasis in the therapy of comborbid patients, for this we need to optimize the drug therapy scheme, as well as the use of multimodal drugs.

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:45
Recommendations of komorbid pathology
01:21
The difference between polymorbid and comorbid pathology
03:00
Charleson Comorbus Evaluation
04:30
Comorbidity phenotypes in age -related patients
05:09
Arterial hypertension and chronic brain ischemia
05:52
Polypragmasis, risks and ways to avoid
14:49
Evidence of neurocytoprotectors medicine
16:02
Mexidol® - Studies of efficiency and safety
16:41
Mexidol® - efficiency and subanalism by age groups

Block of articles on this topic

The influence of Mexidol on the improvement of cognitive status and quality parameters as part of the complex therapy of patients with chronic heart failure of the II - III functional class

Author:
V.V. Tolkacheva, L.V. Karapetyan, N.I. Khutsishvili, S.A. Galochkin, E.R. Kazamedov, railway Kobalava

FGAOU in Russian University of Friendship of Peoples named after Patrice Lumumba, Moscow, Russia

The effectiveness of Mexidol® in patients with neurological complications of type 2 diabetes

Author:
E.L. Pugacheva

FSBEI in "First St. Petersburg State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia, St. Petersburg, Russia

Mexidol® and Mexidol® Fort 250 as part of the sequential therapy for cognitive disorders in comorbide patients with joint pathology against the background of arterial hypertension and coronary heart disease

Authors:
L.N. Eliseeva, S.V. Kartashova

FSBEI in Kuban State Medical University of the Ministry of Health of Russia, Krasnodar

The influence of Mexidol on the quality of life and the functional status of patients with chronic ischemia of the brain and chronic heart failure with a low emission fraction

Authors:
V.V. Tolkacheva ¹ , E.R. Kazamedov ¹ , railway Kobalava ¹ , S.A Galochkin ¹ , A.V. Schulkin ²

¹ FGAOU in Russian University of Friendship of Peoples, Moscow, Russia;
² FSBEI in the Ryazan State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

The effectiveness of the use of ethylmethylhydroxypyridine of succinate in patients with cerebrovascular pathology against the background of diabetes and metabolic syndrome

Authors:
E.V. Ekusheva ^1.2 , E.V. Biryukova ³

¹ FSBI “Academy of post-sex education“ Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical and Biological Agency ”, Moscow, Russia;
² FGAOU Belgorod State National Research University, Belgorod, Russia;
³ FSBEI in the Moscow State Medical and Dome University named after A.I. Evdokimova »Ministry of Health of Russia, Moscow, Russia

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com